Rentabilitas dodolan miturut bathi resik bluebird bio Inc. (BLUE)

Lambang korporat lan logo Bluebird Bio (BLUE)

bluebird bio, Inc. (BLUE) is a pioneer in treating rare blood pathologies using unique lentiviral technologies. The business is based on creating gene therapies from modified patient cells. The integral net margin indicator demonstrates current profitability, where the value -192.40 reflects the metric's balance. However, high product implementation costs and operational complexities create risks in the competitive struggle for market share.

bluebird bio, Inc. (BLUE) - Margin dodolan perusahaan saka 04.07.2022 nganti 07.06.2025

Rincian analitis lan laporan data perusahaan bluebird bio, Inc. (BLUE)

- nilai pasar lan prakiraan target analis:
Analisis kabeh metrik perusahaan:bluebird bio - BLUE
Barang unggulan bluebird bio, Inc

bluebird bio, Inc. (BLUE) focuses on developing innovative one-time gene therapies to treat severe hereditary blood disorders. Mathematically, this process is reflected through the ratio of net income to total revenue. This metric measures the efficiency of converting revenue into final capital after deducting all operating and tax expenses. By analyzing the net profit margin of trading and production activities, an investor assesses the business's resilience to inflation. The trend in the net profit margin of trading and production activities reveals the balance between costly research and development and the market value of patient cures.

Pesaing langsung

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|FDMT - Margin dodolan resik|LXEO: Margin dodolan resik|Korro Bio Inc. - Tingkat bathi resik|EDIT (editasmedicine.com) - Margin dodolan resik|Margin resik SLN|Margin resik ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan resik|Margin resik Sangamo SGMO|NAUT: Rentabilitas dodolan resik|MGX: Rentabilitas dodolan miturut bathi resik|Margin resik Precision BioSciences|GBIO (generationbio.com) - Rentabilitas dodolan miturut bathi resik|Margin resik boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Margin dodolan resik|Rentabilitas dodolan resik IMNN (Imunon, Inc.)|Margin dodolan resik PHIO|MBIO - Margin resik|Margin dodolan resik RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Margin resik|Applied DNA - Margin dodolan resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX